Form 4 for CYTK CYTOKINETICS INC
Accepted 2023-02-09 00:00:00 ET · period of report 2023-02-09 · accession 0001127602-23-004235 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-09 | 2023-02-09 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.96 | +7,000 | 163.6K | +4% | +$55.7K |
| D | 2023-02-09 | 2023-02-09 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $43.74 | -7,000 | 156.6K | -4% | -$306.2K |
| D | 2023-02-09 | 2023-02-09 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $0.00 | -7,000 | 81.3K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-09 | M | A | 7,000 | $7.96 | 163,589 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-09 | S | D | 7,000 | $43.74 | 156,589 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2023-02-09 | M | D | 7,000 | $0.00 | 81,322 | D | $7.96 · 2015-03-26 to 2025-02-26 | 7,000 Common Stock |